← Open Payments lookup

ANISSA MORRIS: Open Payments

NPI 1063120871 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$285 in 15 payments from 9 companies in 2025. Trend: 2023 $335 · 2024 $372 · 2025 $285

Food & beverage: $285
CompanyPaymentsAmount
Merck Sharp & Dohme LLC3$67
Boehringer Ingelheim Pharmaceuticals, Inc.3$55
Novartis Pharmaceuticals Corporation2$30
AstraZeneca Pharmaceuticals LP2$28
Pacira Pharmaceuticals Incorporated1$24
MEDICOMP INC1$23
E.R. Squibb & Sons, L.L.C.1$22
Bayer Healthcare Pharmaceuticals Inc.1$22
Novo Nordisk Inc1$14

Products named: VERQUVO, JARDIANCE, LEQVIO, FARXIGA, Exparel, TELEPATCH CARDIAC MONITOR, CAMZYOS, Kerendia.

Industry payments across TX — which companies pay providers there.